Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than that of the API over the same period. In 2013, China chemical drug preparation industry and China API industry recorded revenue of RMB 573.1 billion and RMB 382 billion, with gross margin of 35%-40% and 20%, respectively.
China is a big producer of chemical APIs, capable of producing about 1,600 varieties of APIs. China ranks first worldwide in output of several bulk APIs including penicillins, vitamins and antipyretic analgesics, and holds a significant share of the featured APIs like statins, prils, sartans in the world. China produced 2.709 million tons of chemical APIs in 2013.
Arusha | Jun-14 | Village-level Energy Innovation Systems in East AfricaSmart Villages
Presentation by Andrew Mnzava, COSTECH - Smart Villages Arusha workshop - June 2014
The workshop in Arusha explored the East African/Tanzanian environment for village energy, local case studies, challenges and opportunities, with a view to formulating policy recommendations for policymakers, funders, NGOs and other stakeholders the region. An important part of the workshop, and indeed the whole Smart Villages initiative work programme, was to gather evidence from existing projects that have provided or facilitated sustainable off-grid energy solutions in the developing world.The workshop gathered more than 50 experts, including policymakers, NGOs, off-grid energy entrepreneurs and others to look for solutions to providing energy to villages off the grid.
ARPA-E Energy Innovation Summit 2011 Keynote Presentation: Secretary Steven ChuUS Department of Energy
1) The document discusses the need for the United States to invest in clean energy innovation in order to win the global clean energy race and capture economic opportunities.
2) Countries like China and those in the EU recognize the economic potential of clean energy and are significantly increasing their investments, while US investment has lagged.
3) Federal support of research and development is critical to driving innovation and ensuring US competitiveness in clean energy technologies like batteries and computing that can create domestic jobs.
Arusha | Jun-14 | Ir Ahmad Zaidee, Off-Grid Renewable Energy SystemsSmart Villages
The workshop in Arusha explored the East African/Tanzanian environment for village energy, local case studies, challenges and opportunities, with a view to formulating policy recommendations for policymakers, funders, NGOs and other stakeholders the region. An important part of the workshop, and indeed the whole Smart Villages initiative work programme, was to gather evidence from existing projects that have provided or facilitated sustainable off-grid energy solutions in the developing world.The workshop gathered more than 50 experts, including policymakers, NGOs, off-grid energy entrepreneurs and others to look for solutions to providing energy to villages off the grid.
Shri Sushilkumar Shinde, Hon'ble Union Minister of Power inaugurated the National Energy Conservation Day Function and gave away the awards for National Energy Conservation and National Level Painting Competiton at Vigyan Bhawan, New Delhi on Monday, 14th December 2009
The document discusses water management strategies in Mithapur, India. It outlines initiatives to improve water availability through integrated watershed development, salinity ingress mitigation, and roof rainwater harvesting projects. Specific projects in villages like Tupni and Bhimrana are highlighted, which constructed check dams, farm ponds, and pipelines to harvest and distribute water. Community participation and ownership are emphasized to ensure sustainable management of water resources.
Arusha | Jun-14 | Village-level Energy Innovation Systems in East AfricaSmart Villages
Presentation by Andrew Mnzava, COSTECH - Smart Villages Arusha workshop - June 2014
The workshop in Arusha explored the East African/Tanzanian environment for village energy, local case studies, challenges and opportunities, with a view to formulating policy recommendations for policymakers, funders, NGOs and other stakeholders the region. An important part of the workshop, and indeed the whole Smart Villages initiative work programme, was to gather evidence from existing projects that have provided or facilitated sustainable off-grid energy solutions in the developing world.The workshop gathered more than 50 experts, including policymakers, NGOs, off-grid energy entrepreneurs and others to look for solutions to providing energy to villages off the grid.
ARPA-E Energy Innovation Summit 2011 Keynote Presentation: Secretary Steven ChuUS Department of Energy
1) The document discusses the need for the United States to invest in clean energy innovation in order to win the global clean energy race and capture economic opportunities.
2) Countries like China and those in the EU recognize the economic potential of clean energy and are significantly increasing their investments, while US investment has lagged.
3) Federal support of research and development is critical to driving innovation and ensuring US competitiveness in clean energy technologies like batteries and computing that can create domestic jobs.
Arusha | Jun-14 | Ir Ahmad Zaidee, Off-Grid Renewable Energy SystemsSmart Villages
The workshop in Arusha explored the East African/Tanzanian environment for village energy, local case studies, challenges and opportunities, with a view to formulating policy recommendations for policymakers, funders, NGOs and other stakeholders the region. An important part of the workshop, and indeed the whole Smart Villages initiative work programme, was to gather evidence from existing projects that have provided or facilitated sustainable off-grid energy solutions in the developing world.The workshop gathered more than 50 experts, including policymakers, NGOs, off-grid energy entrepreneurs and others to look for solutions to providing energy to villages off the grid.
Shri Sushilkumar Shinde, Hon'ble Union Minister of Power inaugurated the National Energy Conservation Day Function and gave away the awards for National Energy Conservation and National Level Painting Competiton at Vigyan Bhawan, New Delhi on Monday, 14th December 2009
The document discusses water management strategies in Mithapur, India. It outlines initiatives to improve water availability through integrated watershed development, salinity ingress mitigation, and roof rainwater harvesting projects. Specific projects in villages like Tupni and Bhimrana are highlighted, which constructed check dams, farm ponds, and pipelines to harvest and distribute water. Community participation and ownership are emphasized to ensure sustainable management of water resources.
Roopa Sree's topic is on edible cutlery as an alternative to plastic cutlery. Edible cutlery is made from natural resources like rice, wheat and sorghum. It can be eaten after use and will decompose within 4-5 days, making it more eco-friendly than plastic cutlery which takes over 450 years to decompose. The first manufacturer of edible cutlery is a company called Bakey's started in 2011 in Hyderabad, India. Edible cutlery has advantages over plastic cutlery like being biodegradable and better for one's health since it can provide some nutrition if eaten.
Technovation: An interactive session in AICTE approved STTP on Cloud Computing, Virtualization and Big Data. The talk covered an overview of what is creativity and innovation on a global scale and how they have impacted the world. Participants have identified a few takeaways: awareness of current trends, how ideas can be crystallized into products, how to mentor and guide projects,the world is changing and we as teachers also need to change.
Slides courtesy: Internet.
Titles and agenda courtesy: Meenakshi Nandula.
The Tata Group is an Indian multinational conglomerate founded in 1868 with 102 companies operating in diverse sectors. It is known for its leadership in corporate social responsibility through initiatives like improving community quality of life, environmental sustainability, and employee welfare. Notable contributions include JRD Tata founding Air India, and the Tata Trusts donating 65% of equity to philanthropic causes like education and healthcare.
The return of high food prices and the need to adapt to climate change have revived interest in agricultural technologies adapted to smallholders, in particular women. Sustainable intensification of smallholder production will require a shift to knowledge-intensive agriculture that combines local knowledge and the latest sustainability science to adapt practices to local ecosystems and increase resilience to climate change, price and other shocks. Poor farmers, often women, usually cultivate in more extreme environments in addition to being less connected to markets. A radical change in the focus of national agricultural plans and substantial investment are needed to unleash smallholder production potential, contributing to achieving MDGs and boosting food production to meet the 70% increase needed by 2050. A holistic approach is needed to raise productivity and resilience of agriculture and supporting ecosystems as well as the efficient and equitable functioning of agricultural supply chains.
The Tata Group is one of India's largest and most respected business conglomerates comprising 96 operating companies across seven business sectors. It has operations in over 54 countries and exports products and services to 120 nations. Established in 1868, the Tata Group employs over 246,000 people and includes major companies such as Tata Steel, Tata Consultancy Services, Tata Motors, and Tata Tea. The Group is guided by five core values and aims to improve the quality of life of communities through leadership in key business sectors.
5 Key Hacks for Breakthrough Innovation Amy Jo Kim
Think like a scientist, laser-focus on early adopters, and gather customer insights early are among the 5 key hacks discussed for breakthrough innovation. The document also provides 3 smart shortcuts - the MVP Canvas, speed interviews, and habit stories - to help clarify strategy, gather early user feedback, and design the product core loop based on existing user habits. A case study of the mobile game Covet Fashion demonstrates how these hacks and shortcuts were applied to successfully validate and launch the product idea.
This document discusses the different levels of strategy employed by Tata Group, including corporate, business, and functional strategies. It provides examples of Tata's growth, acquisition, joint venture, turnaround, divestment, differentiation, value innovation, R&D, operations, and sustainability strategies. Key strategies mentioned include Tata's alliance with NTT DoCoMo, acquisition of Corus and other companies, joint ventures with Starbucks and others, transforming Tata Power Delhi Distribution, and investing over 12,500 crore annually in R&D.
This document discusses how to conserve energy through reducing consumption. It explains that energy can be converted between forms but not created or destroyed. Renewable energy sources like solar and wind can be replenished, unlike non-renewable fossil fuels which are limited. Conserving energy helps preserve resources for future use and saves money. Simple steps like turning off lights and electronics when not in use can help reduce energy waste at home, school, and in public places. Collective conservation efforts can help ensure a sustainable supply of energy for future generations.
The document provides an overview of the Tata Group, a large Indian multinational conglomerate. It discusses the group's history dating back to 1868, its expansion into various sectors such as engineering, energy, chemicals, and consumer products. It also mentions some of the group's acquisitions, awards, innovation initiatives, philanthropic activities, and controversies surrounding land acquisition. The Tata Group operates over 80 companies and is India's largest private employer with over 400,000 employees worldwide.
Tata Chemicals is a leading producer of soda ash and iodized salt in India. In the past year, the company's net revenue increased 6.7% and profit after tax grew 9.7%. Various ratios show the company's improved profitability, returns, and liquidity compared to the previous year. However, some ratios like inventory turnover and debtors turnover indicate room for improvement. The company has strengths in its brands and R&D but also faces weaknesses in global penetration and threats from labor issues and regulations.
The document discusses different types of agriculture practiced in India. It describes primitive subsistence farming, intensive subsistence farming, commercial farming, and plantation farming. It also discusses major crops grown in India like rice, millets, cotton, and coffee. Agricultural development aims to increase farm production to meet population growth through expanding cropped area, irrigation, use of fertilizers and high-yielding seeds, and farm mechanization. The ultimate goal is increased food security. Farming in India has a long history and India ranks second worldwide in agricultural output. In the US, agriculture is a major industry and the country exports food, with over 2 million farms covering over 900 million acres.
Global and china li ion power battery industry report , 2017-2020ResearchInChina
There are three major technology roadmaps for power battery around the world:
(1) Ternary materials-based: NCA and NCM as main cathode materials. Featuring high energy density, NCM batteries have become a mainstream battery technology for electric vehicles along with a sharp cutin procurement costs of the batteries in recent years. Chinese battery enterprises, represented by Tianjin Lishen and Boston Power, have started the production of NCM batteries since 2014. NCA is chiefly used in 18650-type battery (the highest energy density so far), which supports mainly Tesla and Toyota RAV4. However, due to strong chemical activity of aluminum mixed in NCA, advanced BMS is needed to monitor the operating condition of the battery, thus resulting in a low penetration in carmakers.
(2) LFP-based. Canada and the United States were the first countries to develop power battery technology. In China, LFP, the mainstream technology for power lithium battery, is widely used in passenger cars and buses, with the typical enterprises including BYD and Guoxuan High-tech. However, due to the factors like low specific energy and poor low-temperature starting performance, LFP batteries still have not been widely used worldwide.
(3) Manganese series: with LMO as main cathode material. LMO is generally modified and is mixed with a small amount of NCM or LNO to raise battery energy density. Key representative manufacturers are LGC, AESC, LEJ, etc. And in China, they are CITIC Guoan MGL, Do-Fluoride Chemicals, etc.
China silicon carbide industry report, 2016 2020ResearchInChina
Since China's silicon carbide export quota was abolished, China’s silicon carbide export volume grew rapidly during 2013-2014, and tended to stabilize during 2015-2016. In 2016, China’s silicon carbide exports came to 321,500 tons, up 2.1% year on year; wherein, Ningxia’s export volume amounted to 111,900 tons, accounting for 34.9% of the total exports and acting as a main silicon carbide exporter in China.
As China's silicon carbide products are mainly low-end preliminarily processed products with moderate added value, the average price gap between export and import is enormous. In 2016, China's silicon carbide exports had the average price at USD0.9 / kg, less than 1/4 of the import average price (USD4.3 / kg).
Global and china hd map industry research summary, 2016 [兼容模式]ResearchInChina
Overall, autonomous driving is now dominated by automakers, and they will not completely open their underlying data on vehicles to HD map providers. Thus, many auto makers (like Audi, Mercedes-Benz, and BMW), obtain HD map data sources by acquiring digital map providers. In contrast, due to a lack of experience in fault tolerance and underlying data of vehicles, Internet companies end up cooperating with automakers.
Global and china vr and ar industry research summary, 2016 2020 [兼容模式]ResearchInChina
VR Trends:
Gradually-formed industrial standards raise access threshold, thus eliminating less competitive teams and companies;
Large companies gradually build perfect VR ecosystem;
PC VR products, primarily games and movies, will be targeted at expert players and game enthusiasts;
Mobile VR products gradually move into business fields like education and tourism;
The number of content development teams will increase, and the scope of VR contents will broaden.
Global and china natural rubber industry report, 2016 2020ResearchInChina
Due to the sluggish global economic growth and the excess supply of natural rubber, the price of natural rubber has been hovering at a low level. As of the end of 2015, China's natural rubber price had fallen to around USD1,140 / ton which was also the cost price. In 2016, the global average price of natural rubber fluctuates at USD1,200-1,500 / ton.
Automotive PCB market is the biggest highlight. Global automotive PCB market size was USD5.28 billion in 2015 and is expected to grow by 8.3% to USD5.72 billion in 2016 and by 8.2% to USD6.19 billion in 2017, primarily because of impetus of millimeter-wave radar to RF board, of connected vehicle to multi-layer board, and of chassis electronization to metal substrate.
Global and china titanium dioxide industry report, 2016 2020ResearchInChina
In 2015, the global titanium dioxide market size hit EUR10.17 billion, up 3.7% year on year. In 2016-2020, the global market size is expected to present a CAGR of around 4.5% and reach nearly EUR13 billion in 2020.
As consumers have growing awareness of car navigation products as well as telematics develops radically, the global car navigation market witnesses steady development and a higher penetration rate. In 2015, the global embedded automotive navigation system shipment was estimated at 23.9 million sets, with the market size of USD21.6 billion; in 2016, the shipment will reach 25.3 million sets, with the market size up to USD22.6 billion.
From January to May of 2016, China preinstalled 2.074 million sets of car navigation; in 2016, the figure will exceed 5 million sets and hit 5.563 million sets.
Currently, Chinese car navigation map OEMs include NavInfo, AutoNavi (AMAP) and eMapgo Technologies (Beijing); aftermarket map companies embrace Careland, Ritu and NavInfo, among which, NavInfo and Careland occupy the majority of market share in the OEM market and the aftermarket respectively.
In the next few years, China’s preinstalled car navigation will jump year by year, with the expected amount of 9.55 million sets by 2020 and the CAGR of 15% in 2016-2020.
The increase of preinstallation is driven by the two below:
1. The navigation installation ratio of vehicle models for sale increases steadily
As of May 2016, 4,724 models of passenger cars had been on sale in the Chinese market, including 1,782 models equipped with navigation systems, with the installation ratio of 37.7%; among them, Haval’s 130 models had been equipped with navigation systems with the installation ratio of 85%, ranking first. Independent brands, such as Haval, Chang'an, Geely and BYD, played main roles in promoting navigation systems.
2. Automotive navigation has spread gradually from medium and high-end vehicle models to low-end models.
In terms of the navigation installation ratio of vehicle models on sale, 1,245 models tagged with the unit price of RMB200,000 or less were equipped with navigation in May 2016, compared with 1,004 models in? January; correspondingly, the navigation installation ratio ascended from 31.1% to 32.7%. This shows that Chinese car navigation has spread gradually from medium and high-end vehicle models to low-end models.
Global and china supercapacitor industry report, 2016 2020ResearchInChina
The document provides an overview and summary of the "Global and China Supercapacitor Industry Report, 2016-2020" published by ResearchInChina. The report focuses on the global and Chinese supercapacitor market, including market size and forecasts, competitive landscape, key companies, upstream and downstream markets. It also profiles 7 major global and Chinese supercapacitor producers, covering their business overview, operations, products and technologies.
Global and china carbon fiber and cfrp industry report, 2016 2020ResearchInChina
The global carbon fiber demand amounted to 59,000 tons in 2015. 22%, 62% and 16% of carbon fiber were applied to aerospace, industries, and sports & leisure respectively. Specifically, the demand from industries grew fastest, especially from automobiles, wind power, pressure vessels and other market segments. By 2020, 72% of the global carbon fiber will be used in industries, of which 23% will be adopted by automobiles and 21% by wind power.
China etc (electronic toll collection) industry report, 2015 2019ResearchInChina
The Chinese ETC equipment (OBU, RSU) market size has expanded rapidly in recent years, growing at a CAGR of 33.5% during 2012-2014. With advances in networked ETC nationwide, the Chinese ETC equipment market size is estimated to be up to RMB1.35 billion in 2015, presenting a year-on-year jump of 40.5%.
Roopa Sree's topic is on edible cutlery as an alternative to plastic cutlery. Edible cutlery is made from natural resources like rice, wheat and sorghum. It can be eaten after use and will decompose within 4-5 days, making it more eco-friendly than plastic cutlery which takes over 450 years to decompose. The first manufacturer of edible cutlery is a company called Bakey's started in 2011 in Hyderabad, India. Edible cutlery has advantages over plastic cutlery like being biodegradable and better for one's health since it can provide some nutrition if eaten.
Technovation: An interactive session in AICTE approved STTP on Cloud Computing, Virtualization and Big Data. The talk covered an overview of what is creativity and innovation on a global scale and how they have impacted the world. Participants have identified a few takeaways: awareness of current trends, how ideas can be crystallized into products, how to mentor and guide projects,the world is changing and we as teachers also need to change.
Slides courtesy: Internet.
Titles and agenda courtesy: Meenakshi Nandula.
The Tata Group is an Indian multinational conglomerate founded in 1868 with 102 companies operating in diverse sectors. It is known for its leadership in corporate social responsibility through initiatives like improving community quality of life, environmental sustainability, and employee welfare. Notable contributions include JRD Tata founding Air India, and the Tata Trusts donating 65% of equity to philanthropic causes like education and healthcare.
The return of high food prices and the need to adapt to climate change have revived interest in agricultural technologies adapted to smallholders, in particular women. Sustainable intensification of smallholder production will require a shift to knowledge-intensive agriculture that combines local knowledge and the latest sustainability science to adapt practices to local ecosystems and increase resilience to climate change, price and other shocks. Poor farmers, often women, usually cultivate in more extreme environments in addition to being less connected to markets. A radical change in the focus of national agricultural plans and substantial investment are needed to unleash smallholder production potential, contributing to achieving MDGs and boosting food production to meet the 70% increase needed by 2050. A holistic approach is needed to raise productivity and resilience of agriculture and supporting ecosystems as well as the efficient and equitable functioning of agricultural supply chains.
The Tata Group is one of India's largest and most respected business conglomerates comprising 96 operating companies across seven business sectors. It has operations in over 54 countries and exports products and services to 120 nations. Established in 1868, the Tata Group employs over 246,000 people and includes major companies such as Tata Steel, Tata Consultancy Services, Tata Motors, and Tata Tea. The Group is guided by five core values and aims to improve the quality of life of communities through leadership in key business sectors.
5 Key Hacks for Breakthrough Innovation Amy Jo Kim
Think like a scientist, laser-focus on early adopters, and gather customer insights early are among the 5 key hacks discussed for breakthrough innovation. The document also provides 3 smart shortcuts - the MVP Canvas, speed interviews, and habit stories - to help clarify strategy, gather early user feedback, and design the product core loop based on existing user habits. A case study of the mobile game Covet Fashion demonstrates how these hacks and shortcuts were applied to successfully validate and launch the product idea.
This document discusses the different levels of strategy employed by Tata Group, including corporate, business, and functional strategies. It provides examples of Tata's growth, acquisition, joint venture, turnaround, divestment, differentiation, value innovation, R&D, operations, and sustainability strategies. Key strategies mentioned include Tata's alliance with NTT DoCoMo, acquisition of Corus and other companies, joint ventures with Starbucks and others, transforming Tata Power Delhi Distribution, and investing over 12,500 crore annually in R&D.
This document discusses how to conserve energy through reducing consumption. It explains that energy can be converted between forms but not created or destroyed. Renewable energy sources like solar and wind can be replenished, unlike non-renewable fossil fuels which are limited. Conserving energy helps preserve resources for future use and saves money. Simple steps like turning off lights and electronics when not in use can help reduce energy waste at home, school, and in public places. Collective conservation efforts can help ensure a sustainable supply of energy for future generations.
The document provides an overview of the Tata Group, a large Indian multinational conglomerate. It discusses the group's history dating back to 1868, its expansion into various sectors such as engineering, energy, chemicals, and consumer products. It also mentions some of the group's acquisitions, awards, innovation initiatives, philanthropic activities, and controversies surrounding land acquisition. The Tata Group operates over 80 companies and is India's largest private employer with over 400,000 employees worldwide.
Tata Chemicals is a leading producer of soda ash and iodized salt in India. In the past year, the company's net revenue increased 6.7% and profit after tax grew 9.7%. Various ratios show the company's improved profitability, returns, and liquidity compared to the previous year. However, some ratios like inventory turnover and debtors turnover indicate room for improvement. The company has strengths in its brands and R&D but also faces weaknesses in global penetration and threats from labor issues and regulations.
The document discusses different types of agriculture practiced in India. It describes primitive subsistence farming, intensive subsistence farming, commercial farming, and plantation farming. It also discusses major crops grown in India like rice, millets, cotton, and coffee. Agricultural development aims to increase farm production to meet population growth through expanding cropped area, irrigation, use of fertilizers and high-yielding seeds, and farm mechanization. The ultimate goal is increased food security. Farming in India has a long history and India ranks second worldwide in agricultural output. In the US, agriculture is a major industry and the country exports food, with over 2 million farms covering over 900 million acres.
Global and china li ion power battery industry report , 2017-2020ResearchInChina
There are three major technology roadmaps for power battery around the world:
(1) Ternary materials-based: NCA and NCM as main cathode materials. Featuring high energy density, NCM batteries have become a mainstream battery technology for electric vehicles along with a sharp cutin procurement costs of the batteries in recent years. Chinese battery enterprises, represented by Tianjin Lishen and Boston Power, have started the production of NCM batteries since 2014. NCA is chiefly used in 18650-type battery (the highest energy density so far), which supports mainly Tesla and Toyota RAV4. However, due to strong chemical activity of aluminum mixed in NCA, advanced BMS is needed to monitor the operating condition of the battery, thus resulting in a low penetration in carmakers.
(2) LFP-based. Canada and the United States were the first countries to develop power battery technology. In China, LFP, the mainstream technology for power lithium battery, is widely used in passenger cars and buses, with the typical enterprises including BYD and Guoxuan High-tech. However, due to the factors like low specific energy and poor low-temperature starting performance, LFP batteries still have not been widely used worldwide.
(3) Manganese series: with LMO as main cathode material. LMO is generally modified and is mixed with a small amount of NCM or LNO to raise battery energy density. Key representative manufacturers are LGC, AESC, LEJ, etc. And in China, they are CITIC Guoan MGL, Do-Fluoride Chemicals, etc.
China silicon carbide industry report, 2016 2020ResearchInChina
Since China's silicon carbide export quota was abolished, China’s silicon carbide export volume grew rapidly during 2013-2014, and tended to stabilize during 2015-2016. In 2016, China’s silicon carbide exports came to 321,500 tons, up 2.1% year on year; wherein, Ningxia’s export volume amounted to 111,900 tons, accounting for 34.9% of the total exports and acting as a main silicon carbide exporter in China.
As China's silicon carbide products are mainly low-end preliminarily processed products with moderate added value, the average price gap between export and import is enormous. In 2016, China's silicon carbide exports had the average price at USD0.9 / kg, less than 1/4 of the import average price (USD4.3 / kg).
Global and china hd map industry research summary, 2016 [兼容模式]ResearchInChina
Overall, autonomous driving is now dominated by automakers, and they will not completely open their underlying data on vehicles to HD map providers. Thus, many auto makers (like Audi, Mercedes-Benz, and BMW), obtain HD map data sources by acquiring digital map providers. In contrast, due to a lack of experience in fault tolerance and underlying data of vehicles, Internet companies end up cooperating with automakers.
Global and china vr and ar industry research summary, 2016 2020 [兼容模式]ResearchInChina
VR Trends:
Gradually-formed industrial standards raise access threshold, thus eliminating less competitive teams and companies;
Large companies gradually build perfect VR ecosystem;
PC VR products, primarily games and movies, will be targeted at expert players and game enthusiasts;
Mobile VR products gradually move into business fields like education and tourism;
The number of content development teams will increase, and the scope of VR contents will broaden.
Global and china natural rubber industry report, 2016 2020ResearchInChina
Due to the sluggish global economic growth and the excess supply of natural rubber, the price of natural rubber has been hovering at a low level. As of the end of 2015, China's natural rubber price had fallen to around USD1,140 / ton which was also the cost price. In 2016, the global average price of natural rubber fluctuates at USD1,200-1,500 / ton.
Automotive PCB market is the biggest highlight. Global automotive PCB market size was USD5.28 billion in 2015 and is expected to grow by 8.3% to USD5.72 billion in 2016 and by 8.2% to USD6.19 billion in 2017, primarily because of impetus of millimeter-wave radar to RF board, of connected vehicle to multi-layer board, and of chassis electronization to metal substrate.
Global and china titanium dioxide industry report, 2016 2020ResearchInChina
In 2015, the global titanium dioxide market size hit EUR10.17 billion, up 3.7% year on year. In 2016-2020, the global market size is expected to present a CAGR of around 4.5% and reach nearly EUR13 billion in 2020.
As consumers have growing awareness of car navigation products as well as telematics develops radically, the global car navigation market witnesses steady development and a higher penetration rate. In 2015, the global embedded automotive navigation system shipment was estimated at 23.9 million sets, with the market size of USD21.6 billion; in 2016, the shipment will reach 25.3 million sets, with the market size up to USD22.6 billion.
From January to May of 2016, China preinstalled 2.074 million sets of car navigation; in 2016, the figure will exceed 5 million sets and hit 5.563 million sets.
Currently, Chinese car navigation map OEMs include NavInfo, AutoNavi (AMAP) and eMapgo Technologies (Beijing); aftermarket map companies embrace Careland, Ritu and NavInfo, among which, NavInfo and Careland occupy the majority of market share in the OEM market and the aftermarket respectively.
In the next few years, China’s preinstalled car navigation will jump year by year, with the expected amount of 9.55 million sets by 2020 and the CAGR of 15% in 2016-2020.
The increase of preinstallation is driven by the two below:
1. The navigation installation ratio of vehicle models for sale increases steadily
As of May 2016, 4,724 models of passenger cars had been on sale in the Chinese market, including 1,782 models equipped with navigation systems, with the installation ratio of 37.7%; among them, Haval’s 130 models had been equipped with navigation systems with the installation ratio of 85%, ranking first. Independent brands, such as Haval, Chang'an, Geely and BYD, played main roles in promoting navigation systems.
2. Automotive navigation has spread gradually from medium and high-end vehicle models to low-end models.
In terms of the navigation installation ratio of vehicle models on sale, 1,245 models tagged with the unit price of RMB200,000 or less were equipped with navigation in May 2016, compared with 1,004 models in? January; correspondingly, the navigation installation ratio ascended from 31.1% to 32.7%. This shows that Chinese car navigation has spread gradually from medium and high-end vehicle models to low-end models.
Global and china supercapacitor industry report, 2016 2020ResearchInChina
The document provides an overview and summary of the "Global and China Supercapacitor Industry Report, 2016-2020" published by ResearchInChina. The report focuses on the global and Chinese supercapacitor market, including market size and forecasts, competitive landscape, key companies, upstream and downstream markets. It also profiles 7 major global and Chinese supercapacitor producers, covering their business overview, operations, products and technologies.
Global and china carbon fiber and cfrp industry report, 2016 2020ResearchInChina
The global carbon fiber demand amounted to 59,000 tons in 2015. 22%, 62% and 16% of carbon fiber were applied to aerospace, industries, and sports & leisure respectively. Specifically, the demand from industries grew fastest, especially from automobiles, wind power, pressure vessels and other market segments. By 2020, 72% of the global carbon fiber will be used in industries, of which 23% will be adopted by automobiles and 21% by wind power.
China etc (electronic toll collection) industry report, 2015 2019ResearchInChina
The Chinese ETC equipment (OBU, RSU) market size has expanded rapidly in recent years, growing at a CAGR of 33.5% during 2012-2014. With advances in networked ETC nationwide, the Chinese ETC equipment market size is estimated to be up to RMB1.35 billion in 2015, presenting a year-on-year jump of 40.5%.
Global and china low e glass industry report, 2015-2018ResearchInChina
Although China’s Low-E glass capacity grows rapidly, the constraint of production technologies (especially online coating technology) leads to a low capacity utilization rate. In 2014, China’s Low-E glass output ascended 11.9% year on year to 150 million m2, while the capacity utilization rate was only 25.1%. In 2015, the capacity utilization rate is expected to hit 25.8% amid the stable glass market. In addition, China's Low-E glass penetration rate is less than 15%, still lagging far behind 80% in Europe, Japan, South Korea, the United States and other developed countries.
Global and china li ion power battery industry report, 2016-2020ResearchInChina
In 2014, the global demand for Li-ion power battery for electric vehicles came to 9.8GWh, up 87% from a year earlier, of which the demand from passenger vehicles totaled 7.3GWh and commercial vehicles 2.5GWh. In H1 2015, the global demand for EV Li-ion power battery hit 7GWh, maintaining high growth
Global and china graphene industry report, 2015 2018ResearchInChina
Global graphene market size is only USD24.4 million in 2015, and most of demand comes from semiconductor electronics, lithium battery and composite materials industries, which seize a combined 60.1% share. As progress is made in the industrialized application of graphene, global graphene market size is expected to hit USD65 million in 2018.
China tire curing press industry report,2015 2018 ResearchInChina
By the end of 2014, there are about 40 tire curing press manufacturers in China with the annual capacity of 4,500 units or so, mainly distributed in major tire-producing provinces such as Shandong province (Qingdao city), Jiangsu province, Guangdong province. Among them, only Guilin Rubber Machinery and Sino-Rubber Machinery have annual capacity of more than 500 units of curing press, others produce 200-400 units a year. In 2014, Guilin Rubber Machinery, Yiyang Rubber & Plastics Machinery Group, Greatoo Inc., Sino-Rubber Machinery, Guangzhou SCUT Bestry Technology occupied the top five spots of curing press production ranking.
Global and china tyre pressure monitoring system (tpms) industry report, 2015...ResearchInChina
South Korea, European Union, and Taiwan joined the camp that forces the installation of TPMS in 2014, as the former in Jul 2014 and the latter two in Nov 2014 asked that related auto models must be installed with TPMS, directly boosting global demand for the product. Global installation rate of TPMS reached 36% in 2014, up 6 percentage points from 2013, and is expected to exceed 45% in 2015, creating a demand of more than 40 million sets.
This report provides an analysis of China's lubricant industry from 2014-2018. It finds that while China is a major global producer and consumer of lubricants, the market has declined in recent years. State-owned enterprises like Sinopec and PetroChina dominate the market, but privately-owned companies are growing in importance. The report provides an overview of the market size and competitive landscape, as well as profiles of major local and international lubricant companies.
Global and china 3 d printing industry report, 2015 2018ResearchInChina
Since 2010, the global 3D printing market has been in a period of rapid development, with an AAGR of 30% or so. In 2014, the market size totaled USD4.1 billion. 3D printing mainly involves software, equipment, materials and service, of which 3D printing equipment accounted for about 46.5% in the industry in 2014.
China financial leasing industry report, 2015ResearchInChina
Although China’s economic growth posted continuous downturn, China financial leasing industry maintained fast increase since 2014, with total turnover reaching around RMB 3,420 billion as of the end of March 2015, up about RMB 220 billion compared to the end of 2014. The number of enterprises totaled 2,661, an increase of 459 compared to the end of 2014. The number of foreign leasing enterprises enjoyed the fastest growth, being 2,440, an increase of 420.
Global and china automotive seating industry report, 2014 2015ResearchInChina
The seemingly simple automotive seating actually reflects a country's machining ability. In the world, at most 20 companies are capable of producing automotive seating whose frames are made of precision metals via stamping, while nearly a thousand companies have the capability to produce automotive engines.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
2. METHODOLOGY
Both primary and secondary research methodologies were used
in preparing this study. Initially, a comprehensive and exhaustive
search of the literature on this industry was conducted. These
sources included related books and journals, trade literature,
marketing literature, other product/promotional literature, annual
reports, security analyst reports, and other publications.
Subsequently, telephone interviews or email correspondence
was conducted with marketing executives etc. Other sources
included related magazines, academics, and consulting
companies.
INFORMATION SOURCES
The primary information sources include Company Reports,
and National Bureau of Statistics of China etc.
STUDY GOAL AND OBJECTIVES
This report provides the industry executives with strategically significant
competitor information, analysis, insight and projection on the
competitive pattern and key companies in the industry, crucial to the
development and implementation of effective business, marketing and
R&D programs.
REPORT OBJECTIVES
To establish a comprehensive, factual, annually updated and cost-
effective information base on market size, competition patterns,
market segments, goals and strategies of the leading players in the
market, reviews and forecasts.
To assist potential market entrants in evaluating prospective
acquisition and joint venture candidates.
To complement the organizations’ internal competitor information
gathering efforts with strategic analysis, data interpretation and
insight.
To suggest for concerned investors in line with the current
development of this industry as well as the development tendency.
To help company to succeed in a competitive market, and
understand the size and growth rate of any opportunity.
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
Copyright 2012 ResearchInChina
3. Abstract
Chemical pharmaceutical consists mainly of chemical drug preparation
and active pharmaceutical ingredient (API), and the gross margin of
chemical drug preparation industry is generally higher than that of the
API over the same period. In 2013, China chemical drug preparation
industry and China API industry recorded revenue of RMB 573.1 billion
and RMB 382 billion, with gross margin of 35%-40% and 20%,
respectively.
China is a big producer of chemical APIs, capable of producing about
1,600 varieties of APIs. China ranks first worldwide in output of several
bulk APIs including penicillins, vitamins and antipyretic analgesics, and
holds a significant share of the featured APIs like statins, prils, sartans
in the world. China produced 2.709 million tons of chemical APIs in
2013.
Although China is the world's leading chemical APIs supply region, the
concentration of China chemical APIs industry is rather low due to
numerous categories of APIs and limited overall strength of domestic
enterprises, which occupy an important place only in single or a few
categories of pharmaceuticals market. In addition, under the pressure of
both environmental protection and industrial upgrading, many large
APIs companies in the country are transforming into drug preparation
companies through means such as R&D and acquisitions.
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
Copyright 2012ResearchInChina
4. North China Pharmaceutical Group Corp. (NCPC) and Northeast Pharmaceutical Group Co., Ltd. are major suppliers of antibiotic and VC
APIs in China, with supply of VS reaching around 20,000 tons each. In 2013, the two companies’ total revenue from APIs and their revenue
from drug preparation business reached RMB 5.695 billion and RMB 3.871 billion, respectively.
Zhejiang Medicine Co., Ltd. and Zhejiang NHU Co., Ltd. are the leading manufacturers of VE products around the globe, with raw materials
(vital ingredients for the production of VE are limited raw materials: isophytol and trimethylhydroquinone for VE being produced by
themselves. However, the two companies’ development is constrained due to a weak global demand for VE, of which Zhejiang Medicine
reported revenue of RMB 4.915 billion from pharmaceutical business (APIs+ preparation), down 6.3% year on year.
Zhejiang Hisun Pharmaceutical Co., Ltd. and Zhejiang Huahai Pharmaceuticals Co., Ltd. are the key suppliers of featured APIs in China, of
which the former specializes in antineoplastic and cardiovascular products, and the latter, which obtains three certificates from EDQM in
2013, is a major global supplier of prils and sartans APIs. In 2013, the two companies’ total revenues from APIs and drug preparation
business were RMB 3.226 billion and RMB 2.272 billion, rising by 19.5% and 14.7% from the previous year, respectively.
Zhejiang Xianju Pharmaceutical Co., Ltd. and Tianjin Tianyao Pharmaceuticals Co., Ltd. are the leading suppliers of hormone APIs, of
which the former has been aggressively expanding into downstream drug preparation business. In the context of stricter environmental
standards and rising costs of raw materials, developing the downstream will undoubtedly ensure competitiveness of the company. In 2013,
Xianju Pharmaceutical posted total revenue of RMB 2.233 billion from APIs and preparation business, up 16.2% against the prior year. Also
in 2013, the company acquired three EDQM certificates for its APIs.
China Chemical Pharmaceutical Industry Report, 2013-2016 highlights the following:
※ Development status quo, supply and demand, regional structure and trend of global chemical pharmaceutical industry;
※ Development status quo, competitive landscape, import and export and forecast of China chemical pharmaceutical industry;
※ Development status quo, competitive landscape and import and export of China chemical pharmaceutical segments, including vitamins,
antibiotics, antipyretic analgesics, antineoplastics and cardiovascular and cerebrovascular;
※ Operation and prospects of 20 Chinese chemical APIs and preparation companies.
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
Copyright 2012ResearchInChina
5. 1. Overview of Chemical Pharmaceutical Industry
1.1 Definition and Classification
1.2 Industry Chain
2. Development of Global Chemical
Pharmaceutical Industry
2.1 Status Quo
2.2 Supply and Demand
2.2.1 Product Mix
2.2.1 Regional Structure
2.3 Major Countries and Regions
2.3.1 North America
2.3.2 Europe
2.3.3 Emerging Countries
2.4 Development Trends
2.4.1 Proprietary Drugs in Trouble, Generic Drugs with
Great Potential
2.4.2 Emerging Countries Being Growth Engines
3. Development of China Chemical Pharmaceutical
Industry
3.1 Status Quo
3.1.1 Overall Conditions
3.1.2 Improvement in Pharmaceutical Innovation
Capability
3.1.3 Active Merger and Reorganization of
Pharmaceutical Companies
3.2 Operating Capability
3.3 Import and Export
Table of contents
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
3.3.1 Chemical Preparations
3.3.2 Chemical APIs
3.4 Competitive Landscape
4. China Chemical Pharmaceutical Market
Segments
4.1 Vitamins
4.1.1 Status Quo
4.1.2 Competitive Landscape
4.1.3 Import and Export
4.2 Antibiotics
4.2.1 Status Quo
4.2.2 Competitive Landscape
4.2.3 Import and Export
4.3 Antipyretic Analgesics
4.3.1 Status Quo
4.3.2 Competitive Landscape
4.3.3 Import and Export
4.4 Hormones
4.4.1 Status Quo
4.4.2 Competitive Landscape
4.4.3 Import and Export
4.5 Anti-tumor
4.6 Cardiovascular and Cerebrovascular
5. Key Chinese Chemical APIs Manufacturers
5.1 Northeast Pharmaceutical Group Co., Ltd.
5.2 North China Pharmaceutical Co., Ltd.
5.3 Zhejiang Medicine Co., Ltd.
5.4 Zhejiang Hisun Pharmaceutical Co., Ltd.
5.5 Zhejiang NHU Co., Ltd.
5.6 Shandong Xinhua Pharmaceutical Company
Limited
5.7 Shenzhen Hepalink Pharmaceutical Co., Ltd.
5.8 Zhejiang Xianju Pharmaceutical Co., Ltd.
5.9 Zhejiang Huahai Pharmaceutical Co., Ltd.
5.10 Tianjin Tianyao Pharmaceuticals Co., Ltd.
6. Key Chinese Chemical Preparation Manufacturers
6.1 China Resources Double-Crane Pharmaceutical
Co., Ltd.
6.2 Jiangsu Hengrui Medicine Co., Ltd.
6.3 Harbin Pharm. Group Sanjing Pharmaceutical
Shareholding Co., Ltd.
6.4 Xizang Haisco Pharmaceutical Group Co., Ltd.
6.5 Livzon Pharmaceutical Group Inc.
6.6 Shanghai Fosun Pharmaceutical (Group) Co.,
Ltd.
6.7 Jiangsu Nhwa Pharmaceutical Co., Ltd.
6.8 Hainan Haiyao Co., Ltd.
6.9 Huaren Pharmaceutical Co., Ltd.
6.10 Humanwell Healthcare (Group) Co., Ltd.
7. Conclusion and Forecast
7.1 Overall
7.1.1 Market Size Forecast
7.1.2 Profit Forecast
7.2 Companies
6. • Classification of Sub-sectors of China Chemical Pharmaceutical Industry
• Profit Distribution of Chemical Pharmaceutical Industry
• Size and YoY Growth Rate of Global Pharmaceuticals Market, 2003-2013
• M&A Transaction Value in Global Pharmaceutical Industry, 2013
• Global Top10 Mergers and Acquisitions in Pharmaceutical Industry, 2013
• Number of New Drugs Approved by FDA, 2010-2013
• New Drugs Approved by FDA and Sales, 2013
• Blockbuster Drugs and Sales of 15 Large Global Pharmaceutical Companies, 2013
• Sales Proportion of Global Generic Drugs, 2008-2013
• Regional Distribution of Global Pharmaceutical Industry
• Size and YoY Growth Rate of Global Pharmaceuticals Market by Country and Region, 2012
• Proportion of Spending on Health Care to GDP in the U.S. and Canada, 1995-2012
• Pharmaceuticals Sales in the United States, 2010-2012
• Proportion of Spending on Health Care to GDP in Britain and France, 1995-2012
• Pharmaceuticals Sales in Western Europe, 2010-2012
• Pharmaceuticals Sales in Emerging Countries, 2010-2012
• Contributions of Emerging Countries to Global Pharmaceuticals Sales Growth, 2010-2012
• Real GDP Growth Rates of China, U.S., Britain and India, 2000-2012
• Total Output Value and % of GDP of China Chemical Pharmaceutical Industry, 2010-2013
• Comparison of Revenue from China Chemical APIs and Preparation Industries, 2010-2013
• Output of Chemical APIs in China, 2007-2013
• Pharmaceuticals Approved for Marketing in China, 2013
• Revenue and Profit of China Chemical Preparation Industry, 2010-2013
• Revenue and Profit of China Chemical APIs Industry, 2010-2013
• Gross Margin of China Chemical Preparation and Chemical APIs Industry, 2010-2013
Selected Charts
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
7. • Import and Export Value of Chemical APIs in China, 2010-2013
• Export Value and YoY Growth Rate of Featured APIs in China, 2010-2013
• Regional Distribution of China’s Chemical API Export by Value, 2013
• Chemical Pharmaceuticals Purchase Amount Breakdown of China’s Hospitals by Disease Pattern, 2012
• Output and % of Vitamin in Export Volume in China, 2010-2013
• Major Vitamin C Companies and Their Output in China, 2012
• Major Vitamin E Companies and Their Output in China, 2012
• Export Volume and Value and Average Price of China’s Vitamins, 2009-2013
• Proportion of Export Volume of China’s Vitamins by Product, 2008-2013
• Export Destinations of China’s Vitamins, 2013
• Import Volume and Value and Average Price of Vitamins in China, 2010-2013
• Proportion of Import Volume of Vitamins in China by Product, 2008-2013
• Sources of Imported Vitamins in China, 2013
• Output of Main Antibiotic APIs in China, 2012
• Output of Main Antibiotic Preparations in China, 2012
• Manufacturers and Output of Main Antibiotic APIs in China, 2012
• Import Volume and Value of Antibiotics in China, 2008-2013
• Export Volume and Value of Antibiotics in China, 2008-2013
• Output and Export Volume of Antipyretic Analgesics APIs in China, 2012
• Export Volume of Antipyretic Analgesics APIs in China, 2012
• Export Structure of Antipyretic Analgesics APIs in China by Volume, 2012
• Hormone Drugs Output in China, 2010-2012
• Output of Main Hormone APIs in China, 2012
• Export Volume and Value of Hormone Products in China, 2013
• Purchase Amount and Proportion of Main Antineoplastic and Immunoregulatory Drugs in Typical Hospitals of 22 Cities in China, 2012
Selected Charts
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
8. • Purchase Amount and Proportion of Main Cardiovascular System Drugs in Typical Hospitals of 22 Cities in China, 2012
• Revenue and Net Income of Northeast Pharmaceutical, 2010-2013
• Output and Export Volume of VC Series Products of Northeast Pharmaceutical, 2011-2012
• Operating Revenue of Northeast Pharmaceutical by Product, 2010-2013
• Operating Revenue of Northeast Pharmaceutical by Region, 2010-2013
• Revenue and Net Income of Northeast Pharmaceutical, 2013-2016E
• Output and Export Volume of Some APIs of North China Pharmaceutical, 2012
• Revenue and Net Income of North China Pharmaceutical, 2009-2013
• Operating Revenue of North China Pharmaceutical by Product, 2009-2013
• Operating Revenue of North China Pharmaceutical by Region, 2009-2013
• R&D Costs and % of Revenue of North China Pharmaceutical, 2011-2013
• Revenue and Net Income of North China Pharmaceutical, 2013-2016E
• Output and Export Volume of Some APIs of Zhejiang Medicine, 2012
• Revenue and Net Income of Zhejiang Medicine, 2009-2013
• Revenue of Zhejiang Medicine by Product, 2009-2013
• Revenue of Zhejiang Medicine by Region, 2009-2013
• R&D Costs and % of Revenue of Zhejiang Medicine, 2011-2013
• Revenue and Net Income of Zhejiang Medicine, 2013-2016E
• Revenue and Net Income of Zhejiang Hisun Pharmaceutical, 2010-2013
• Operating Revenue of Zhejiang Hisun Pharmaceutical by Product, 2009-2013
• Operating Revenue of Zhejiang Hisun Pharmaceutical by Region, 2009-2013
• R&D Costs and % of Revenue of Zhejiang Hisun Pharmaceutical, 2010-2013
• Revenue and Net Income of Zhejiang Hisun Pharmaceutical, 2013-2016E
• Revenue and Net Income of Zhejiang NHU Co., Ltd., 2009-2013
• Operating Revenue of Zhejiang NHU Co., Ltd. by Product, 2010-2013
Selected Charts
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
9. • Operating Revenue of Zhejiang NHU Co., Ltd. by Region, 2010-2013
• R&D Costs and % of Revenue of Zhejiang NHU Co., 2010-2014
• Revenue and Net Income of Zhejiang NHU Co., 2013-2016E
• Revenue and Net Income of Shandong Xinhua Pharmaceutical, 2009-2013
• Operating Revenue of Shandong Xinhua Pharmaceutical by Product, 2010-2013
• Main Products and % of Revenue of Shandong Xinhua Pharmaceutical, 2013
• Revenue and Net Income of Shandong Xinhua Pharmaceutical, 2013-2016E
• Revenue and Net Income of Shenzhen Hepalink Pharmaceutical, 2009-2013
• Operating Revenue of Shenzhen Hepalink Pharmaceutical by Product, 2009-2013
• Operating Revenue of Shenzhen Hepalink Pharmaceutical by Region, 2009-2013
• R&D Costs and % of Revenue of Shenzhen Hepalink Pharmaceutical, 2009-2013
• Revenue and Net Income of Zhejiang Xianju Pharmaceutical, 2009-2013
• Operating Revenue of Zhejiang Xianju Pharmaceutical by Product, 2009-2013
• Operating Revenue of Zhejiang Xianju Pharmaceutical by Region, 2009-2013
• R&D Costs and % of Revenue of Zhejiang Xianju Pharmaceutical, 2010-2013
• Revenue and Net Income of Zhejiang Xianju Pharmaceutical, 2013-2016E
• Revenue and Net Income of Zhejiang Huahai Pharmaceutical, 2009-2013
• Revenue of Zhejiang Huahai Pharmaceutical by Product, 2009-2013
• Revenue of Zhejiang Huahai Pharmaceutical by Region, 2010-2013
• R&D Costs and % of Revenue of Zhejiang Huahai Pharmaceutical, 2011-2013
• Revenue and Net Income of Zhejiang Huahai Pharmaceutical, 2013-2016E
• Revenue and Net Income of Tianjin Tianyao Pharmaceuticals, 2010-2013
• Revenue of Tianjin Tianyao Pharmaceuticals by Product, 2010-2013
• Revenue of Tianjin Tianyao Pharmaceuticals by Region, 2010-2013
• R&D Costs and % of Revenue of Tianjin Tianyao Pharmaceuticals, 2013
Selected Charts
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
10. • Investment Projects of Tianjin Tianyao Pharmaceuticals, 2013
• Revenue and Net Income of Tianjin Tianyao Pharmaceuticals, 2013-2016E
• Revenue and Net Income of China Resources Double-Crane Pharmaceutical, 2010-2013
• Revenue Structure of China Resources Double-Crane Pharmaceutical by Sector, 2010-2013
• Gross Margin of China Resources Double-Crane Pharmaceutical by Product, 2013
• Revenue of China Resources Double-Crane Pharmaceutical by Region, 2010-2013
• Construction Projects Invested by China Resources Double-Crane Pharmaceutical, 2013
• R&D Expenditure Structure of China Resources Double-Crane Pharmaceutical, 2013
• Revenue and Net Income of China Resources Double-Crane Pharmaceutical, 2013-2016E
• Revenue and Net Income of Jiangsu Hengrui Medicine, 2010-2013
• Operating Revenue of Jiangsu Hengrui Medicine by Product, 2010-2013
• R&D Expenditure of Jiangsu Hengrui Medicine, 2013
• Progress of Investment Projects of Jiangsu Hengrui Medicine as of 2013
• Revenue and Net Income of Jiangsu Hengrui Medicine, 2013-2016E
• Revenue and Net Income of Harbin Pharm. Group Sanjing Pharmaceutical Shareholding, 2010-2013
• Operating Revenue of Harbin Pharm. Group Sanjing Pharmaceutical Shareholding by Product, 2010-2013
• R&D Expenditure of Harbin Pharm. Group Sanjing Pharmaceutical Shareholding, 2013
• Revenue and Net Income of Xizang Haisco Pharmaceutical, 2010-2013
• Revenue and Gross Margin of Xizang Haisco Pharmaceutical by Product, 2013
• Revenue of Xizang Haisco Pharmaceutical by Region, 2010-2013
• Investment Projects of Xizang Haisco Pharmaceutical, 2013
• R&D Expenditure of Xizang Haisco Pharmaceutical, 2010-2013
• Revenue and Net Income of Xizang Haisco Pharmaceutical, 2013-2016E
• Revenue and Net Income of Livzon Pharmaceutical Group, 2008-2013
Selected Charts
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
11. • Operating Revenue of Livzon Pharmaceutical Group by Product, 2008-2013
• Operating Revenue of Livzon Pharmaceutical Group by Region, 2008-2013
• Revenue and Net Income of Livzon Pharmaceutical Group, 2013-2016E
• Revenue and Net Income of Shanghai Fosun Pharmaceutical, 2008-2013
• Operating Revenue of Shanghai Fosun Pharmaceutical by Product, 2008-2013
• Operating Revenue of Shanghai Fosun Pharmaceutical by Region, 2008-2013
• R&D Costs and % of Revenue of Shanghai Fosun Pharmaceutical, 2008-2013
• Revenue and Net Income of Shanghai Fosun Pharmaceutical, 2013-2016E
• Revenue and Net Income of Jiangsu Nhwa Pharmaceutical, 2009-2013
• Revenue of Jiangsu Nhwa Pharmaceutical by Product, 2009-2013
• R&D Costs and % of Revenue of Jiangsu Nhwa Pharmaceutical, 2010-2013
• Revenue and Net Income of Jiangsu Nhwa Pharmaceutical, 2013-2016E
• Revenue and Net Income of Hainan Haiyao, 2009-2013
• Operating Revenue of Hainan Haiyao by Product, 2009-2013
• R&D Costs and % of Revenue of Hainan Haiyao, 2011-2013
• Revenue and Net Income of Hainan Haiyao, 2013-2016E
• Revenue and Net Income of Huaren Pharmaceutical, 2010-2013
• Revenue of Huaren Pharmaceutical by Product, 2010-2013
• Gross Margin of Huaren Pharmaceutical by Product, 2010-2013
• Revenue of Huaren Pharmaceutical by Region, 2013
• Investment Projects of Huaren Pharmaceutical, 2013
• Mergers and Acquisitions Conducted by Huaren Pharmaceutical, 2013
• R&D Expenditure of Huaren Pharmaceutical, 2011-2013
• Revenue and Net Income of Huaren Pharmaceutical, 2013-2016E
• Revenue and Net Income of Humanwell Healthcare, 2010-2013
Selected Charts
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
12. • Revenue and Gross Margin of Humanwell Healthcare by Product, 2013
• Revenue of Humanwell Healthcare by Region, 2010-2013
• Project Investment of Humanwell Healthcare, 2013
• Equity Investment of Humanwell Healthcare, 2013
• Revenue and Net Income of Humanwell Healthcare, 2013-2016E
• Number of People Aged 65 and Over and Percentage of Total Population, 2004-2013
• Revenue of Chemical Preparations and Chemical APIs in China, 2010-2016E
• Gross Margin of Chemical Preparations and Chemical APIs in China, 2010-2016E
• Revenue and Main Products of Key Chemical APIs Companies in China, 2013
• Revenue of Key Chemical Preparations Companies in China, 2013
Selected Charts
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
13. You can place your order in the following alternative ways:
1.Order online at www.researchinchina.com
2.Fax order sheet to us at fax number:+86 10 82601570
3. Email your order to: report@researchinchina.com
4. Phone us at +86 10 82600828/ 82601561
Party A:
Name:
Address:
Contact Person: Tel
E-mail: Fax
Party B:
Name: Beijing Waterwood Technologies Co., Ltd (ResearchInChina)
Address: Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18,
Suzhou Street, Haidian District, Beijing, China 100080
Contact
Person:
Liao Yan Phone: 86-10-82600828
E-mail: report@researchinchina.com Fax: 86-10-82601570
Bank details: Beneficial Name: Beijing Waterwood Technologies Co., Ltd
Bank Name: Bank of Communications, Beijing Branch
Bank Address: NO.1 jinxiyuan shijicheng,Landianchang,Haidian
District,Beijing
Bank Account No #: 110060668012015061217
Routing No # : 332906
Bank SWIFT Code: COMMCNSHBJG
Title Format Cost
Total
Choose type of format
PDF (Single user license) …………..2,500 USD
Hard copy ………………….……. 2,700 USD
PDF (Enterprisewide license)…....... 3,900 USD
※ Reports will be dispatched immediately
once full payment has been received.
Payment may be made by wire transfer or
credit card via PayPal.
How to Buy
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
14. About ResearchInChina
ResearchInChina (www.researchinchina.com) is a leading independent provider of China business intelligence. Our
research is designed to meet the diverse planning and information needs of businesses, institutions, and professional
investors worldwide. Our services are used in a variety of ways, including strategic planning, product and sales forecasting,
risk and sensitivity management, and as investment research.
Our Major Activities
Multi-users market reports
Database-RICDB
Custom Research
Company Search
RICDB (http://www.researchinchina.com/data/database.html ), is a visible financial data base presented by map and graph
covering global and China macroeconomic data, industry data, and company data. It has included nearly 500,000 indices
(based on time series), and is continuing to update and increase. The most significant feature of this base is that the vast
majority of indices (about 400,000) can be displayed in map.
After purchase of our report, you will be automatically granted to enjoy 2 weeks trial service of RICDB for free.
After trial, you can decide to become our formal member or not. We will try our best to meet your demand. For more
information, please find at www.researchinchina.com
For any problems, please contact our service team at:
Room 502, Block 3, Tower C, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080
Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● report@researchinchina.com
RICDB service